Literature DB >> 1777159

Oligomeric nature of transmembrane glycoproteins of HIV-2: procedures for their efficient dissociation and preparation of Western blots for diagnosis.

B S Parekh1, C P Pau, T C Granade, M Rayfield, K M De Cock, H Gayle, G Schochetman, J R George.   

Abstract

Western blot (WB) analysis of various strains of HIV-2 indicated that transmembrane glycoprotein (TMP) of HIV-2 exists as trimers. These trimers have molecular weights and electrophoretic mobilities in the region of the major external glycoprotein, gp120, resulting in WB misidentification during diagnosis. A simple and rapid procedure was developed using trichloroacetic acid (TCA) to efficiently dissociate oligomeric forms of the TMP to monomers prior to the preparation of WB. This procedure permitted the unambiguous identification of antibodies to gp120 and to the TMP. Use of HIV-2 WB strips without any oligomeric forms of the TMP demonstrated (1) that cross reactivity of HIV-1-positive specimens on HIV-2 WB was mainly directed to Gag and Pol proteins, with some reactivity to gp36/gp41 TMP, but none to gp120; (2) that these strips can substantially reduce the number of specimens falsely identified as dually (HIV-1 and HIV-2) reactive; and (3) that HIV-2-positive specimens reacted to viral gp120 in a strain-specific manner, demonstrating high antigenic variation in this glycoprotein. It is recommended that this general procedure of viral protein dissociation be used for HIV-2 WB preparation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777159

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry.

Authors:  Qingsheng Li; Ming Zeng; Lijie Duan; James E Voss; Anthony J Smith; Stefan Pambuccian; Liang Shang; Stephen Wietgrefe; Peter J Southern; Cavan S Reilly; Pamela J Skinner; Mary L Zupancic; John V Carlis; Michael Piatak; Diane Waterman; R Keith Reeves; Katherine Masek-Hammerman; Cynthia A Derdeyn; Michael D Alpert; David T Evans; Heinz Kohler; Sybille Müller; James Robinson; Jeffrey D Lifson; Dennis R Burton; R Paul Johnson; Ashley T Haase
Journal:  J Immunol       Date:  2014-08-18       Impact factor: 5.422

2.  Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.

Authors:  S A Hammond; S J Cook; D L Lichtenstein; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

3.  Field evaluation of a combination of monospecific enzyme-linked immunosorbent assays for type-specific diagnosis of human immunodeficiency virus type 1 (HIV-1) and HIV-2 infections in HIV-seropositive persons in Abidjan, Ivory Coast.

Authors:  J N Nkengasong; C Maurice; S Koblavi; M Kalou; C Bile; D Yavo; E Boateng; S Z Wiktor; A E Greenberg
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

4.  Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.

Authors:  Q J Sattentau; J P Moore; F Vignaux; F Traincard; P Poignard
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

5.  Comparison of indirect immunofluorescence and membrane fluorescence assays for the differentiation of antibodies to human immunodeficiency virus types 1 and 2.

Authors:  D Gallo; M N Hoffman; E T Yeh; J R George; C V Hanson
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

6.  Reproducing SIVΔnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines.

Authors:  James E Voss; Matthew S Macauley; Kenneth A Rogers; Francois Villinger; Lijie Duan; Liang Shang; Elizabeth A Fink; Raiees Andrabi; Arnaud D Colantonio; James E Robinson; R Paul Johnson; Dennis R Burton; Ashley T Haase
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

7.  Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.

Authors:  Konstantin Virnik; Margherita Rosati; Alexei Medvedev; Aaron Scanlan; Gabrielle Walsh; Frances Dayton; Kate E Broderick; Mark Lewis; Yvonne Bryson; Jeffrey D Lifson; Ruth M Ruprecht; Barbara K Felber; Ira Berkower
Journal:  PLoS One       Date:  2020-03-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.